BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8404857)

  • 21. Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma.
    Thornburg NJ; Pathmanathan R; Raab-Traub N
    Cancer Res; 2003 Dec; 63(23):8293-301. PubMed ID: 14678988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diverse molecular mechanisms of inhibition of NF-kappa B/DNA binding complexes by I kappa B proteins.
    Léveillard T; Verma IM
    Gene Expr; 1993; 3(2):135-50. PubMed ID: 8268718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The interferon-inducible p202a protein modulates NF-kappaB activity by inhibiting the binding to DNA of p50/p65 heterodimers and p65 homodimers while enhancing the binding of p50 homodimers.
    Ma XY; Wang H; Ding B; Zhong H; Ghosh S; Lengyel P
    J Biol Chem; 2003 Jun; 278(25):23008-19. PubMed ID: 12676938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NF-kappa B-inducible BCL-3 expression is an autoregulatory loop controlling nuclear p50/NF-kappa B1 residence.
    Brasier AR; Lu M; Hai T; Lu Y; Boldogh I
    J Biol Chem; 2001 Aug; 276(34):32080-93. PubMed ID: 11387332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B.
    Schmitz ML; Baeuerle PA
    EMBO J; 1991 Dec; 10(12):3805-17. PubMed ID: 1935902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct association of pp40/I kappa B beta with rel/NF-kappa B transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity.
    Inoue J; Kerr LD; Rashid D; Davis N; Bose HR; Verma IM
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4333-7. PubMed ID: 1533932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes.
    Heissmeyer V; Krappmann D; Wulczyn FG; Scheidereit C
    EMBO J; 1999 Sep; 18(17):4766-78. PubMed ID: 10469655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The proto-oncogene bcl-3 encodes an I kappa B protein.
    Kerr LD; Duckett CS; Wamsley P; Zhang Q; Chiao P; Nabel G; McKeithan TW; Baeuerle PA; Verma IM
    Genes Dev; 1992 Dec; 6(12A):2352-63. PubMed ID: 1459457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of transcription by B cell Leukemia 3 (Bcl-3) protein requires interaction with nuclear factor κB (NF-κB) p50.
    Collins PE; Kiely PA; Carmody RJ
    J Biol Chem; 2014 Mar; 289(10):7059-7067. PubMed ID: 24459141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The activity of a 70 kilodalton I kappa B molecule identical to the carboxyl terminus of the p105 NF-kappa B precursor is modulated by protein kinase A.
    Gerondakis S; Morrice N; Richardson IB; Wettenhall R; Fecondo J; Grumont RJ
    Cell Growth Differ; 1993 Aug; 4(8):617-27. PubMed ID: 8398903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T cell leukemia-associated human Notch/translocation-associated Notch homologue has I kappa B-like activity and physically interacts with nuclear factor-kappa B proteins in T cells.
    Guan E; Wang J; Laborda J; Norcross M; Baeuerle PA; Hoffman T
    J Exp Med; 1996 May; 183(5):2025-32. PubMed ID: 8642313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of NF-kappa B.
    Naumann M; Wulczyn FG; Scheidereit C
    EMBO J; 1993 Jan; 12(1):213-22. PubMed ID: 8428580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Common structural constituents confer I kappa B activity to NF-kappa B p105 and I kappa B/MAD-3.
    Hatada EN; Naumann M; Scheidereit C
    EMBO J; 1993 Jul; 12(7):2781-8. PubMed ID: 8334994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NF- kappa B2/p100 induces Bcl-2 expression.
    Viatour P; Bentires-Alj M; Chariot A; Deregowski V; de Leval L; Merville MP; Bours V
    Leukemia; 2003 Jul; 17(7):1349-56. PubMed ID: 12835724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel NF-kappa B complex containing p65 homodimers: implications for transcriptional control at the level of subunit dimerization.
    Ganchi PA; Sun SC; Greene WC; Ballard DW
    Mol Cell Biol; 1993 Dec; 13(12):7826-35. PubMed ID: 8246997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bcl-3 and NFkappaB p50-p50 homodimers act as transcriptional repressors in tolerant CD4+ T cells.
    Grundström S; Anderson P; Scheipers P; Sundstedt A
    J Biol Chem; 2004 Feb; 279(9):8460-8. PubMed ID: 14668329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tax protein of human T-cell leukemia virus type I binds to the ankyrin motifs of inhibitory factor kappa B and induces nuclear translocation of transcription factor NF-kappa B proteins for transcriptional activation.
    Hirai H; Suzuki T; Fujisawa J; Inoue J; Yoshida M
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3584-8. PubMed ID: 8170951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TNF-alpha gene expression in macrophages: regulation by NF-kappa B is independent of c-Jun or C/EBP beta.
    Liu H; Sidiropoulos P; Song G; Pagliari LJ; Birrer MJ; Stein B; Anrather J; Pope RM
    J Immunol; 2000 Apr; 164(8):4277-85. PubMed ID: 10754326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site.
    Bours V; Burd PR; Brown K; Villalobos J; Park S; Ryseck RP; Bravo R; Kelly K; Siebenlist U
    Mol Cell Biol; 1992 Feb; 12(2):685-95. PubMed ID: 1531086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NF-kappaB mediates mitogen-activated protein kinase pathway-dependent iNOS expression in human melanoma.
    Uffort DG; Grimm EA; Ellerhorst JA
    J Invest Dermatol; 2009 Jan; 129(1):148-54. PubMed ID: 18668140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.